Business ❯Pharmaceuticals ❯AbbVie

Acquisitions

Cerevel Therapeutics ImmunoGen

AbbVie Acquires Cerevel Therapeutics for $8.7 Billion

AbbVie Acquires Neuroscience Biotech Cerevel for $8.7 Billion